Tuberculosis treatment by restoring sensitivity to key drugs with Mycobacterial Tolerance Inhibitor
| Diarienummer | |
| Koordinator | QURETECH BIO AB - QURETECH BIO AB c/o Akiri AB |
| Bidrag från Vinnova | 4 000 kronor |
| Projektets löptid | september 2016 - september 2016 |
| Status | Avslutat |